| __timestamp | CRISPR Therapeutics AG | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 1513000 | 60987000 |
| Thursday, January 1, 2015 | 12573000 | 125542000 |
| Friday, January 1, 2016 | 42238000 | 210460000 |
| Sunday, January 1, 2017 | 69800000 | 275119000 |
| Monday, January 1, 2018 | 113773000 | 409539000 |
| Tuesday, January 1, 2019 | 179362000 | 547758000 |
| Wednesday, January 1, 2020 | 269407000 | 736300000 |
| Friday, January 1, 2021 | 17953000 | 904200000 |
| Saturday, January 1, 2022 | 110250000 | 1080300000 |
| Sunday, January 1, 2023 | 130250000 | 1262200000 |
| Monday, January 1, 2024 | -2314000 | 1530500000 |
Cracking the code
In the ever-evolving landscape of biotechnology, understanding the financial dynamics of leading companies is crucial. Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG, two giants in the field, have shown distinct trends in their cost of revenue over the past decade. From 2014 to 2023, Vertex Pharmaceuticals has consistently outpaced CRISPR Therapeutics, with its cost of revenue peaking at approximately $1.26 billion in 2023, a staggering 20-fold increase from 2014. In contrast, CRISPR Therapeutics, while showing growth, reached a cost of revenue of around $130 million in 2023, marking a significant rise from its 2014 figure. This comparison highlights Vertex's expansive operational scale and CRISPR's steady growth trajectory. As the biotech sector continues to innovate, these financial insights provide a window into the strategic priorities and market positioning of these industry leaders.
Analyzing Cost of Revenue: Novartis AG and CRISPR Therapeutics AG
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Alkermes plc's Expenses
Vertex Pharmaceuticals Incorporated or CRISPR Therapeutics AG: Who Manages SG&A Costs Better?
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs CRISPR Therapeutics AG
Cost Insights: Breaking Down Biogen Inc. and CRISPR Therapeutics AG's Expenses
Analyzing Cost of Revenue: Viatris Inc. and CRISPR Therapeutics AG
Cost of Revenue Trends: Ionis Pharmaceuticals, Inc. vs CRISPR Therapeutics AG
CRISPR Therapeutics AG vs PTC Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: CRISPR Therapeutics AG and Geron Corporation